Latest AMGN Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Akash Tewari | Jefferies | Initiates | Hold | $350.00 | |
| Emily Field | Barclays | Initiates | Hold | $350.00 | |
| Mohit Bansal | Wells Fargo | Maintains | Hold | $325.00 → $375.00 +50.00 (15.4%) | |
| David Amsellem | Piper Sandler | Maintains | Buy | $381.00 → $432.00 +51.00 (13.4%) | |
| Ilya Zubkov | Freedom Broker | Downgrades | Hold | $360.00 → $375.00 +15.00 (4.2%) | |
| Jasper Hellweg | Argus Research | Maintains | Strong Buy | $360.00 → $400.00 +40.00 (11.1%) | |
| Vamil Divan | Guggenheim | Maintains | Hold | $305.00 → $347.00 +42.00 (13.8%) | |
| Google Drug Manufacturers - General | TipRanks - Google | Reiterates | Buy | $388.00 → $412.00 +24.00 (6.2%) | |
| PerPlexity Drug Manufacturers - General | TipRanks - PerPlexity | Reiterates | Buy | $386.00 → $421.00 +35.00 (9.1%) | |
| Anthropic Drug Manufacturers - General | TipRanks - Anthropic | Reiterates | Hold | $372.00 → $385.00 +13.00 (3.5%) | |
| DeepSeek Drug Manufacturers - General | TipRanks - DeepSeek | Reiterates | Buy | $383.00 → $421.00 +38.00 (9.9%) | |
| xAi Drug Manufacturers - General | TipRanks - xAI | Reiterates | Buy | $379.00 → $410.00 +31.00 (8.2%) | |
| OpenAI Drug Manufacturers - General | TipRanks - OpenAI | Downgrades | Buy | $369.00 → $406.00 +37.00 (10.0%) | |
| Louise Chen | Scotiabank | Maintains | Buy | $385.00 | |
| Carter Gould | Cantor Fitzgerald | Maintains | Hold | $315.00 → $350.00 +35.00 (11.1%) | |
| Matt Phipps | William Blair | Maintains | Buy | - | |
| David Amsellem | Piper Sandler | Reiterates | Buy | $381.00 | |
| Gregory Renza | Truist | Maintains | Hold | $319.00 | |
| David Risinger | Leerink Partners | Maintains | Buy | $305.00 → $355.00 +50.00 (16.4%) | |
| Salveen Richter | Goldman Sachs | Maintains | Buy | $415.00 | |
| Evan Seigerman | BMO Capital | Maintains | Buy | $372.00 | |
| Geoff Meacham | Citi | Maintains | Hold | $315.00 → $345.00 +30.00 (9.5%) | |
| Luca Issi | RBC Capital | Reiterates | Buy | $335.00 → $360.00 +25.00 (7.5%) | |
| Umer Raffat | Evercore ISI Group | Maintains | Buy | - | |
| Terence Flynn | Morgan Stanley | Maintains | Hold | $304.00 → $309.00 +5.00 (1.6%) | |
| Yaron Werber | TD Cowen | Reiterates | Buy | $389.00 → $420.00 +31.00 (8.0%) | |
| Jay Olson | Oppenheimer | Maintains | Buy | $380.00 → $400.00 +20.00 (5.3%) | |
| Tazeen Ahmad | BofA Securities | Maintains | Sell | $304.00 | |
| Michael Yee | UBS | Maintains | Strong Buy | $380.00 → $390.00 +10.00 (2.6%) | |
| Mohit Bansal | Wells Fargo | Maintains | Hold | $325.00 | |
| Edmund Ingham | Forbes | Initiates Coverage | Buy | - | |
| Nico Chen | DBS | Maintains | Buy | $400.00 | |
| Courtney Breen | Bernstein | Downgrades | Hold | $335.00 → $335.00 +0.00 (0.0%) | |
| David Risinger | Leerink Partners | Maintains | Hold | - | |
| Gregory Renza | Truist | Maintains | Hold | $318.00 → $319.00 +1.00 (0.3%) | |
| David Amsellem | Piper Sandler | Reiterates | Buy | $381.00 | |
| Michael Yee | UBS | Initiates | Strong Buy | $317.00 → $380.00 +63.00 (19.9%) |
